• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿科炎症性肠病患者循环中的α4β7记忆T细胞表达多克隆T细胞受体库。

Circulating α4β7 Memory T Cells in Pediatric IBD Patients Express a Polyclonal T Cell Receptor Repertoire.

作者信息

Gamliel Adir, Werner Lael, Pinsker Marina, Salamon Naomi, Weiss Batia, Shouval Dror S

机构信息

Pediatric Gastroenterology Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel.

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

出版信息

Clin Exp Gastroenterol. 2020 Oct 2;13:439-447. doi: 10.2147/CEG.S271565. eCollection 2020.

DOI:10.2147/CEG.S271565
PMID:33061522
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7537844/
Abstract

BACKGROUND

The integrin α4β7 is highly expressed on activated T cells and is thought to direct homing of lymphocytes to the intestine. Since ulcerative colitis (UC) and Crohn's disease (CD) are characterized by mucosal oligoclonal T cells' expansion, we aimed to assess whether similar repertoire features are identified in circulating gut-specific memory T cells.

METHODS

Memory CD3 T cells were isolated from blood samples of control subjects and patients with active UC or CD and then FACS-sorted into α4β7 and α4β7 populations. DNA was extracted from each subset and subjected to next-generation sequencing of the TCRβ. Different repertoire characteristics were compared between α4β7 and α4β7 subsets for each subject, and between groups.

RESULTS

The percentages of memory T cells and α4β7 cells were comparable between groups. α4β7 memory T cells displayed a polyclonal distribution, in control subjects and in UC or CD patients, with similar indices of diversity. Strikingly, the clonal overlap between α4β7 and α4β7 T cells for each subject in all three groups was high, ranging between 20%-50%. We were unable to identify shared T cell clones that were specific to one of the groups.

CONCLUSION

α4β7 memory T cells exhibited a polyclonal repertoire in both control subjects and patients with active inflammatory bowel disease, with high rates of overlap with α4β7 memory T cells. Our study, along with additional recent reports, may suggest that the suppression of intestinal inflammation by vedolizumab is independent of the drug's effect on T cell migration to the gut.

摘要

背景

整合素α4β7在活化的T细胞上高度表达,被认为可引导淋巴细胞归巢至肠道。由于溃疡性结肠炎(UC)和克罗恩病(CD)的特征是黏膜寡克隆T细胞扩增,我们旨在评估在循环的肠道特异性记忆T细胞中是否能发现类似的谱系特征。

方法

从对照受试者以及活动性UC或CD患者的血样中分离记忆性CD3 T细胞,然后通过荧光激活细胞分选术(FACS)分为α4β7阳性和α4β7阴性群体。从每个亚群中提取DNA,并进行TCRβ的下一代测序。比较每个受试者α4β7阳性和α4β7阴性亚群之间以及各群体之间不同的谱系特征。

结果

各群体之间记忆T细胞和α4β7阳性细胞的百分比相当。在对照受试者以及UC或CD患者中,α4β7阳性记忆T细胞呈多克隆分布,具有相似的多样性指数。令人惊讶的是,所有三组中每个受试者的α4β7阳性和α4β7阴性T细胞之间的克隆重叠率都很高,在20%至50%之间。我们无法识别出特定于某一组的共享T细胞克隆。

结论

在对照受试者和活动性炎症性肠病患者中,α4β7阳性记忆T细胞均表现出多克隆谱系,与α4β7阴性记忆T细胞的重叠率很高。我们的研究以及最近的其他报告可能表明,维多珠单抗对肠道炎症的抑制作用独立于该药物对T细胞迁移至肠道的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e4/7537844/7affca361882/CEG-13-439-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e4/7537844/b2ab1e593df0/CEG-13-439-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e4/7537844/87c79e30c171/CEG-13-439-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e4/7537844/9d595730afe1/CEG-13-439-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e4/7537844/7affca361882/CEG-13-439-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e4/7537844/b2ab1e593df0/CEG-13-439-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e4/7537844/87c79e30c171/CEG-13-439-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e4/7537844/9d595730afe1/CEG-13-439-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0e4/7537844/7affca361882/CEG-13-439-g0004.jpg

相似文献

1
Circulating α4β7 Memory T Cells in Pediatric IBD Patients Express a Polyclonal T Cell Receptor Repertoire.儿科炎症性肠病患者循环中的α4β7记忆T细胞表达多克隆T细胞受体库。
Clin Exp Gastroenterol. 2020 Oct 2;13:439-447. doi: 10.2147/CEG.S271565. eCollection 2020.
2
Association of Vedolizumab Level, Anti-Drug Antibodies, and α4β7 Occupancy With Response in Patients With Inflammatory Bowel Diseases. vedolizumab 水平、抗药物抗体和 α4β7 占有率与炎症性肠病患者反应的相关性。
Clin Gastroenterol Hepatol. 2018 May;16(5):697-705.e7. doi: 10.1016/j.cgh.2017.11.050. Epub 2017 Dec 7.
3
T Cell Repertoire Homogeneity and Blood-Gut Overlap in Patients With Inflammatory Bowel Disease.T 细胞 repertoire 同质性和炎症性肠病患者的血液-肠道重叠。
Cell Mol Gastroenterol Hepatol. 2024;17(1):119-130. doi: 10.1016/j.jcmgh.2023.09.003. Epub 2023 Sep 13.
4
Comparison of the integrin α4β7 expression pattern of memory T cell subsets in HIV infection and ulcerative colitis.比较 HIV 感染和溃疡性结肠炎中记忆 T 细胞亚群的整合素 α4β7 表达模式。
PLoS One. 2019 Jul 29;14(7):e0220008. doi: 10.1371/journal.pone.0220008. eCollection 2019.
5
Vedolizumab Efficacy Is Associated With Decreased Intracolonic Dendritic Cells, Not Memory T Cells.维得利珠单抗的疗效与减少结内树突状细胞有关,而与记忆 T 细胞无关。
Inflamm Bowel Dis. 2024 May 2;30(5):704-717. doi: 10.1093/ibd/izad224.
6
Non-classical monocyte homing to the gut via α4β7 integrin mediates macrophage-dependent intestinal wound healing.非经典单核细胞通过 α4β7 整合素归巢至肠道,介导巨噬细胞依赖性肠道伤口愈合。
Gut. 2020 Feb;69(2):252-263. doi: 10.1136/gutjnl-2018-316772. Epub 2019 May 15.
7
Vedolizumab blocks α4β7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitis.维多珠单抗可阻断微小性结肠炎中α4β7整合素介导的T细胞与黏膜地址素细胞黏附分子-1的黏附。
Therap Adv Gastroenterol. 2022 Jun 28;15:17562848221098899. doi: 10.1177/17562848221098899. eCollection 2022.
8
Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo.α4β7和GPR15对溃疡性结肠炎患者效应性T细胞和调节性T细胞体内归巢至炎症肠道的不同影响。
Gut. 2016 Oct;65(10):1642-64. doi: 10.1136/gutjnl-2015-310022. Epub 2015 Jul 24.
9
CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease.CCR9拮抗剂:在炎症性肠病治疗中的潜力。
Clin Exp Gastroenterol. 2015 Apr 7;8:119-30. doi: 10.2147/CEG.S48305. eCollection 2015.
10
Altered T cell receptor beta repertoire patterns in pediatric ulcerative colitis.儿童溃疡性结肠炎中 T 细胞受体 β 谱的改变。
Clin Exp Immunol. 2019 Apr;196(1):1-11. doi: 10.1111/cei.13247. Epub 2019 Jan 27.

本文引用的文献

1
Genomic profiling of intestinal T-cell receptor repertoires in inflammatory bowel disease.炎症性肠病中肠道 T 细胞受体库的基因组分析。
Genes Immun. 2020 Feb;21(2):109-118. doi: 10.1038/s41435-020-0092-x. Epub 2020 Feb 7.
2
Identification of Disease-associated Traits and Clonotypes in the T Cell Receptor Repertoire of Monozygotic Twins Affected by Inflammatory Bowel Diseases.鉴定受炎症性肠病影响的同卵双胞胎的 T 细胞受体库中的疾病相关特征和克隆型。
J Crohns Colitis. 2020 Jul 9;14(6):778-790. doi: 10.1093/ecco-jcc/jjz179.
3
Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease.
维得利珠单抗治疗活动期克罗恩病患者的内镜、放射学和组织学愈合。
Gastroenterology. 2019 Oct;157(4):1007-1018.e7. doi: 10.1053/j.gastro.2019.06.038. Epub 2019 Jul 4.
4
The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapies.整合素在炎症性肠病发病机制中的作用:已批准和正在研究的抗整合素疗法。
Med Res Rev. 2020 Jan;40(1):245-262. doi: 10.1002/med.21601. Epub 2019 Jun 19.
5
Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advances.免疫细胞在炎症性肠病中的迁移和滞留:机制见解和治疗进展。
Gut. 2019 Sep;68(9):1688-1700. doi: 10.1136/gutjnl-2018-317977. Epub 2019 May 24.
6
Non-classical monocyte homing to the gut via α4β7 integrin mediates macrophage-dependent intestinal wound healing.非经典单核细胞通过 α4β7 整合素归巢至肠道,介导巨噬细胞依赖性肠道伤口愈合。
Gut. 2020 Feb;69(2):252-263. doi: 10.1136/gutjnl-2018-316772. Epub 2019 May 15.
7
T cell clonal expansions in ileal Crohn's disease are associated with smoking behaviour and postoperative recurrence.回肠克罗恩病中的 T 细胞克隆扩增与吸烟行为和术后复发有关。
Gut. 2019 Nov;68(11):1961-1970. doi: 10.1136/gutjnl-2018-317878. Epub 2019 Feb 12.
8
Altered T cell receptor beta repertoire patterns in pediatric ulcerative colitis.儿童溃疡性结肠炎中 T 细胞受体 β 谱的改变。
Clin Exp Immunol. 2019 Apr;196(1):1-11. doi: 10.1111/cei.13247. Epub 2019 Jan 27.
9
Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis.阿柏西普治疗中重度溃疡性结肠炎的随机、安慰剂对照试验的疗效和安全性。
Gastroenterology. 2019 Mar;156(4):946-957.e18. doi: 10.1053/j.gastro.2018.11.035. Epub 2018 Nov 23.
10
Deep Remission With Vedolizumab in Patients With Moderately to Severely Active Ulcerative Colitis: A GEMINI 1 post hoc Analysis.维得利珠单抗治疗中重度活动溃疡性结肠炎患者的深度缓解:GEMINI 1 事后分析。
J Crohns Colitis. 2019 Feb 1;13(2):172-181. doi: 10.1093/ecco-jcc/jjy149.